Nanoparticles (NPs) 
Introduction
The immune system is the primary defense barrier presented by living organisms when foreign entities try to gain access to the body, or when cells or molecules become a potential threat to the body, such as in the case of cancer or many types of autoimmune diseases. The ability to modulate the immune response is important in a wide array of contexts, including the prevention of bacterial infection, the treatment of cancer and the suppression of the autoimmune response. [ 1 ] Antibodies, cytokines, oligonucleotides, and small molecules have been used as immunotherapy agents. [ 2 ] For example, hydrogen sulfi de (H 2 S) can induce an upregulation of anti-infl ammatory and cytoprotective genes, resulting in pronounced anti-infl ammatory activity. [ 3 ] While "small" molecules are important tools for immune modulation, macromolecular systems offer size and structural features ideal for interaction with the immune system. Among these materials, nanoparticles (NPs) hold promise as therapeutics for modulating the response of the immune system. Important implications of the control of immunological responses range from the prevention of diseases (by the enhancement of vaccines and immunotherapies), to the development of new stealth drug delivery vehicles. [ 4 ] By the precise chemical design, a range of NP platforms have been developed and studied for therapeutic applications. Engineered NPs can protect the payload (drug or antigen) from the biological surroundings, increase circulatory lifetime, reduce cytotoxicity, and target cells and tissues. [ 5 ] Through choice of particle size, shape, and core materials, NPs can be engineered to be recognized by the immune system, causing stimulation or suppression of immune reactions. For example, ZnO NPs induce the production of proinfl ammatory cytokines, while CeO 2 and TiO 2 NPs do not cause any effects. [ 6 ] Mechanisms of uptake can be regulated as well: polypyrrole NPs were internalized into IMR 90 cells via endocytosis, but internalized via both phagocytosis and endocytosis into J774A.1 cells. [ 7 ] Immune activation occurs through multiple mechanisms, including receptors at the surface of cells that recognize specifi c molecular patterns, and systems of proteins that recognize chemical signals, such as the complement system. Different types of immunological responses are triggered depending on how the immune system recognizes foreign entities.
[ 8 ] Recognition by the immune system can cause elimination of nanomaterials (and a decrease in therapeutic efficiency if the NP is a carrier); however, the same phenomenon can be employed as a tool to generate immunotherapies. As such, exploring the interaction between NPs and the immune system is of critical importance for the development of fundamentally new NP-based therapies.
Modifying the physical and chemical properties of nanomaterials concomitantly alters their immunological response. Size affects cellular uptake pathway, cell penetration, cytotoxicity, and bio-distribution of NPs in the immune system. [ 9 ] Here, we focus on recent efforts to understand the structureactivity relationships of immune responses caused by NP surfaces, and how therapeutic benefi ts can be achieved through appropriate NP engineering. We focus here on the use of intrinsic NP properties as opposed to the use of specifi c antigens of known activity (e.g., oligonucleotides, proteins, long peptides), exploring how these synthetic motifs can be used to elicit therapeutically useful immune responses.
Immune Recognition
The immune system can be categorized into two distinct processes: innate and adaptive. The innate immune response constitutes the fi rst, primal, host defense, and is induced by both selective cellular processes (performed primarily by phagocytic cells), [ 10 ] and constitutive and non-specifi c events such as in the case of complement systems (complex multicomponent systems of proteins) that must be activated to function. [ 11, 12 ] Once these systems are triggered, the second part of the immune system, adaptive immunity, is then able to respond in a highly specifi c manner against molecular determinants on pathogens in a longer-term process that can proceed over weeks. [ 13 ] When NPs enter the mammalian body, stimulation of the immune system is normally initiated by the interaction of these materials with innate immune cells such as monocytes, macrophages and dendritic cells, in a similar manner to a pathogen infection. This interaction leads to signal cascades upon activation of pattern recognition receptors (PRRs). [ 14 ] PRRs are proteins expressed by innate immune cells to identify pathogen-associated molecular patterns (PAMPs) associated with microbial pathogens or cellular stress. Other types of receptors include the damage-associated molecular patterns (DAMPs) associated with cell components released during cell damage.
Signaling PRRs include the large families of membranebound Toll-like receptors (TLRs) [ 15 ] that can recognize such diverse molecular structures such as nucleic acids (single and double stranded), bacterial fragments such as Lipopolysaccharides (LPS), and charged phospholipids. [16] In addition, cytoplasmic nucleotide oligomerization domain (NOD)-like receptors (NLRs) recognize cytoplasmic proteins, and have a variety of functions in the regulation of infl ammation and apoptotic responses. [ 17 ] On the other hand, endocytic PRRs promote the attachment, engulfment and destruction of microorganisms/foreign entities by phagocytes, without relaying an intracellular signal. Endocytic PRRs recognize carbohydrates, and include mannose receptors on macrophages, glycan receptors present on all phagocytes, and scavenger receptors, found on all phagocytes, that recognize charged ligands and mediate removal of apoptotic cells. [ 18 ] 3. Immunogenicity and Nanoparticle Surfaces
General Considerations
The use of NPs as carriers for the delivery of therapeutic molecules is one of the major applications of nanomaterials in biological systems. Substantial research has been directed towards the development of carriers that have minimal interaction with the immune system, with the objective of increasing delivery effi ciency. One of the properties that most delivery vehicles share is the presence of a net positive charge at the surface, often used for complementarity with the therapeutic molecule (i.e., nucleic acids and/or anionic proteins), or generated as a result of the surfactant that is used to create the NPs. [ 19 ] However, cationic systems induce the activation of infl ammatory responses, even when used in concentrations below the cytotoxic threshold. For example, Peer et al. performed a systematic study of the effect of the NP charge in the expression of cytokines, markers of immune activation. [20] They observed that positively-charged lipid NPs produced a strong immunological effect, 10-20 fold higher than that for neutral and anionic NPs. This study, and others, [ 21 ] suggest that a family of receptors may be involved in the specifi c recognition of cationic systems. However, this is not the only way by which the immune system can identify foreign charged structures.
Another effect that needs to be taken into consideration is the non-specifi c adsorption of proteins over the NP surface, namely the formation of a protein corona. When NPs are injected in the mammalian body, this corona tends to include a series of proteins called opsonins (such as C1q and C3b), whose sole function is to tag foreign bodies for their rapid elimination. [ 22, 23 ] The binding of these proteins to charged NP surfaces induces activation of the complement system and macrophage recruitment, initiating the cascade of immune responses. [ 12 ] As a result of these clearance processes, NPs that form a protein corona (positively or negatively charged) are eliminated from the bloodstream more quickly than particles with stealth capabilities ( Figure 1 ). 23 24 
Poly(ethylene Glycol) (PEG): The "Stealth" Coating
PEGylation is one of the most popular approaches to control the stability of NPs in biological fl uids that not only reduces non-specifi c protein adsorption, but also improves the circulation time of NPs. After PEG modifi cation, nanoparticles can be decorated with different molecular structures such as antibodies, oligonucleotides, and peptides, allowing their use in active targeting and immunotherapy. However, despite the perception of PEG as the ideal non-fouling coating, PEG derivatives are recognized by the immune system, triggering different immune responses. For example, Jiang et al. demonstrated that PEGylated NPs could induce the secretion of anti-PEG antibodies, accelerating the blood clearance of these systems ( Figure 2 a) . [ 25 ] They also observed that other chemical functionalities that confer non-fouling characteristics (i.e., zwitterions) did not trigger the formation of antibodies, and hence do not cause accelerated blood clearance. Different reports on the recognition of PEG structures by proteins from the complement system (similar to cationic NPs) have been also presented. [ 26 ] These studies suggest that the density and chain length of PEG are crucial determinants for the immunogenicity of these systems, as these parameters infl uence cellular binding, uptake, and degradation. [ 27 ] Likewise, this activation of the complement system (and the adsorption of those proteins in the corona) by PEG has been shown to affect the biodistribution, pharmacokinetics and the overall behavior of nanomaterials in vivo. [ 28 ] It is important to note that the use of PEG might also compromise the effi cacy and safety of nanomaterials in biomedical applications. As an example, in vivo studies showed that PEG small 2016, 12, No. 1, 76-82 (5000)-coated AuNPs induced acute infl ammation and apoptosis in the livers of mice. [ 29 ] The immunogenic properties of PEG, however, can also be tailored for use in therapy. As an example, Hubbell et al. used PEG modifi ed NPs as a platform to both deliver and boost the recognition of a specifi c antigen. [ 30 ] Using inverse emulsion polymerization, PEG and poly(propylene glycol) (PPG) were copolymerized to obtain NPs that were effi ciently and quickly taken into lymphatic vessels and transported to lymph nodes, achieving the intended delivery and increasing the immunological outcome. The study suggested that the presence of PEG is crucial for this process, as the binding of hydroxyl terminal groups with the exposed thioester of the complement protein C3b initiates complement activation and induced dendritic cell maturation (Figure 2 b) . As a result, the PEG-NPs induced a strong adjuvant activity when conjugated with ovalbumin (a commonly used model antigen), up-regulating both humoral and cellular immunity, and producing strong levels of anti-ovalbumin IgG.
Hydrophobic Surfaces for Immune Activation
As described above, the hydrophobic moieties such as aliphatic and aromatic groups found in DAMPs and PAMPs are hypothesized to be involved in the activation of the immune system. [ 31 ] As such, it is considered that hydrophobic portions that are normally hidden inside the cellular membrane may serve as danger signals. [ 23 ] Copyright 2000, Informa UK Limited. b) Nanoparticles that form a protein corona (TTMA and TCOOH, with positive and negative charges, respectively) are eliminated from the bloodstream faster than neutral nanoparticles (TEGOH and TZwit). Reproduced with permission. [ 24 ] Copyright 2011, Public Library of Science.
functionalized NPs with different degrees of hydrophobicity, and measured cytokine expression after exposing splenocytes to the NPs. [ 32 ] Their fi ndings showed a direct correlation between the hydrophobicity of NPs and cytokine expression, while other functionalities such as h-bond donors/acceptors, did not affect the response ( Figure 3 a) . Interestingly, this effect was observed for pro-and anti-infl ammatory cytokines both in vitro and in vivo, indicating a signifi cant control of these immune responses. Similar results were observed more recently by the Santos group by the use of thermally hydrocarbonized porous silicon NPs, reporting not only an increase in the cytokine expression, but also an increase in the maturation of dendritic cells (DCs). [ 33 ] Likewise, other studies using poly(D,L-lactic acid) (PLA), poly(D,L-lactic-co-glycolic acid) (PLGA), and poly-(monomethoxypolyethylene glycol-co-D,L-lactide), polymers that offer different degrees of hydrophobicity while maintaining constant particle size, demonstrated an increase in antigen internalization by dendritic cells for particles of larger hydrophobicity, along with an increase in CD86 and MCH II expression (Figure 3 b) . [ 34 ] Finally, hydrophobic moieties have also been correlated to an increase in adjuvant capabilities by the use of poly (g-glutamic acid) (PGA) with different grafting degrees with to L-phenylalanine ethyl ester. [ 35 ] This system showed an increase in antibody generation (alongside an increase in infl ammatory cytokines) when the grafting degree of the particles was larger (more hydrophobic). Taken together, these results suggest the generality of the phenomenon, and show the signifi cant potential of hydrophobic portions for their use in modulating immune responses towards NPs.
Perspectives
We have discussed how different chemical functionalities at the NP surface are recognized by the immune system, and how this recognition can be exploited for therapeutic purposes. However, two important considerations need to be addressed to gain more detailed information on how we can use these interactions during the design of nanomaterials. The fi rst one is how nanomaterials can interact with the complement system. Most of the studies found in literature are limited to in vitro analysis of the interactions of NPs with different cells of the immune system. However, it is important to note that when nanomaterials are injected in the body, they not only interact directly with cells from the immune system, but also with the "tagging" system of the complement system. This second process may be the reason why many in vivo studies do not correlate to in vitro tests, limiting the scope of the fi ndings. In addition, opsonization of nanoparticles with complement proteins is one of the initial steps for the elimination of these materials from the bloodstream (decreasing therapeutic effi ciency), evidencing its central role in the immunological environment. Systematic studies of the activation of the complement by the surface functionality (such as the one depicted for PEG) and by other NP properties are scarce, despite their signifi cance for a better prediction of the in vivo behavior of nanomaterials. As such, a better understanding of the rules that govern complement recognition of nanomaterials is of fundamental importance, and efforts should be directed towards this goal.
Another important factor is the fact that most of the immunotherapeutic applications of nanomaterials are www.small-journal.com directed towards the generation of better vaccine adjuvants (increase an immune response, as discussed before), and very few studies attempt the control or reduction of an immunological effect that is already present. This limited scope reduces the applicability of most of the fi ndings to prophylactic applications; preventive therapy that is given when the body is not currently under a stress or a disease. It is unknown if these NPs will possess the same behavior once the system has been challenged by another stressor, for example in the case of infl ammation. Infl ammation plays a major role in the development of different diseases, and various immunotherapies have been proposed for its treatment. However, even in the case of such a critical immunological challenge, attempts to use nanoparticle-based therapies to gain control are scarce. Furthermore, as no fundamental studies addressing the interaction of nanomaterials and a "stressed" immune system have been performed, we possess very few clues on the fundamental behavior of these systems. This challenge offers an excellent opportunity to not only undercover fundamentals of the immune recognition, but alsoto open new doors for the development of nanomaterials for non-prophylactic use, a new generation of remedial immunotherapies.
Conclusion
We have come a long way with regards to understanding the interaction between NPs and the immune system. NP surfaces can now be engineered to achieve desired immunological responses by the use of different chemical functionalities that avoid or trigger distinct immune activities. Surface coverages such as PEG and zwitterions provide "stealth" functionality, important for the delivery community. Surface engineering to generate immune responses, presents a huge area for potential therapeutics. We have already witnessed the development of new nano-adjuvants to boost the responses of antigens. This immunostimulation is just the tip of the iceberg. Nanomaterials have the potential to provide tailored responses that would enable targeted proand anti-infl ammatory responses that could revolutionize the address of health concerns as diverse as autoimmune diseases, infections, and cancer. However, much remains to be learned fundamentally before we can truly tap the potential of NPs for immunomodulation.
